Literature DB >> 19388852

Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus.

Dagmar Kiesslich1, Myuki Alfaia Crispim, Carlos Santos, Fernando de Lima Ferreira, Nelson Abrahim Fraiji, Shirley Vasconcelos Komninakis, Ricardo Sobhie Diaz.   

Abstract

OBJECTIVE: We evaluated the influence of hepatitis B virus (HBV) genotype on the course of disease in patients coinfected with HBV and hepatitis delta virus (HDV).
METHODS: We evaluated HBV genotypes in 190 patients, 140 of whom had chronic HBV monoinfection and 50 of whom had chronic HBV-HDV coinfection. Real-time polymerase chain reactions for the amplification of HBV DNA and HDV RNA were developed, and we compared the patient groups with respect to HBV genotype, viral load, alanine aminotransferase (ALT) and bilirubin levels, and disease severity.
RESULTS: Coinfected patients had higher ALT and bilirubin levels as well as a higher prevalence of liver cirrhosis and liver carcinoma. ALT levels were higher among individuals coinfected with HDV and HBV genotype F than among individuals infected only with HBV genotype F. Among HDV-HBV-coinfected patients, HDV load was lower among those infected with HBV genotype A than among those infected with HBV genotype D or genotype F.
CONCLUSION: Liver inflammation and HDV load are influenced by HBV genotype in individuals coinfected with HBV and HDV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19388852     DOI: 10.1086/598955

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Current concept in the pathophysiology of hepatitis delta infection.

Authors:  Grazia Anna Niro; Antonina Smedile
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  Life cycle and pathogenesis of hepatitis D virus: A review.

Authors:  Zaigham Abbas; Rafia Afzal
Journal:  World J Hepatol       Date:  2013-12-27

Review 3.  Hepatitis D virus coinfection and superinfection.

Authors:  Francesco Negro
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 4.  Is there any value to hepatitis B virus genotype analysis?

Authors:  Sudeep Tanwar; Geoffrey Dusheiko
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 5.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

6.  Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon.

Authors:  Márcia da Costa Castilho; Cintia Mara Costa de Oliveira; João Bosco de Lima Gimaque; Jorge Di Tommaso Leão; Wornei Silva Miranda Braga
Journal:  Am J Trop Med Hyg       Date:  2012-08-20       Impact factor: 2.345

Review 7.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

8.  Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.

Authors:  Antonio Madejón; Míriam Romero; Ángela Hernández; Araceli García-Sánchez; Marta Sánchez-Carrillo; Antonio Olveira; Javier García-Samaniego
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

Review 9.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

10.  Hepatitis B virus genotypes and evolutionary profiles from blood donors from the northwest region of China.

Authors:  Xing-Bin Hu; Qiao-Hong Yue; Xian-Qing Zhang; Xue-Qing Xu; Yin Wen; Yao-Zhen Chen; Xiao-Dong Cheng; Liu Yang; Shi-Jie Mu
Journal:  Virol J       Date:  2009-11-17       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.